MTDPS2
MCID: MTC062
MIFTS: 30

Mitochondrial Dna Depletion Syndrome 2 (MTDPS2)

Categories: Bone diseases, Cardiovascular diseases, Ear diseases, Eye diseases, Gastrointestinal diseases, Genetic diseases, Liver diseases, Metabolic diseases, Muscle diseases, Nephrological diseases, Neuronal diseases, Rare diseases

Aliases & Classifications for Mitochondrial Dna Depletion Syndrome 2

MalaCards integrated aliases for Mitochondrial Dna Depletion Syndrome 2:

Name: Mitochondrial Dna Depletion Syndrome 2 57 12 75 29 13 6 73
Mtdps2 57 75
Mitochondrial Dna Depletion Syndrome 2 Myopathic Type 75
Mitochondrial Dna Depletion Syndrome, Myopathic Form 59
Mitochondrial Dna Depletion Myopathy, Tk2-Related 57
Mitochondrial Dna Depletion Myopathy Tk2-Related 75
Myopathic Mitochondrial Dna Depletion Syndrome 75
Mitochondrial Dna Depletion Syndrome, Type 2 40
Mtdna Depletion Syndrome, Myopathic Form 59

Characteristics:

Orphanet epidemiological data:

59
mitochondrial dna depletion syndrome, myopathic form
Inheritance: Autosomal recessive; Prevalence: <1/1000000 (Worldwide); Age of onset: Infancy,Neonatal;

OMIM:

57
Inheritance:
autosomal recessive

Miscellaneous:
variable severity
progressive disorder
later onset has been reported
onset usually by age 2 years


HPO:

32
mitochondrial dna depletion syndrome 2:
Onset and clinical course variable expressivity phenotypic variability infantile onset progressive
Inheritance autosomal recessive inheritance


Classifications:



Summaries for Mitochondrial Dna Depletion Syndrome 2

OMIM : 57 Mitochondrial DNA depletion syndrome-2 is an autosomal recessive disorder characterized primarily by childhood onset of muscle weakness associated with depletion of mtDNA in skeletal muscle. There is wide clinical variability; some patients have onset in infancy and show a rapidly progressive course with early death due to respiratory failure, whereas others have later childhood onset of a slowly progressive myopathy (Oskoui et al., 2006). For a discussion of genetic heterogeneity of autosomal recessive mtDNA depletion syndromes, see MTDPS1 (603041). (609560)

MalaCards based summary : Mitochondrial Dna Depletion Syndrome 2, also known as mtdps2, is related to tk2-related mitochondrial dna depletion syndrome, myopathic form and tk2-related mitochondrial dna maintenance defect, myopathic form. An important gene associated with Mitochondrial Dna Depletion Syndrome 2 is TK2 (Thymidine Kinase 2, Mitochondrial). Affiliated tissues include skeletal muscle, liver and bone, and related phenotypes are seizures and muscular hypotonia

UniProtKB/Swiss-Prot : 75 Mitochondrial DNA depletion syndrome 2: A disorder due to mitochondrial dysfunction characterized by childhood onset of muscle weakness associated with depletion of mtDNA in skeletal muscle. There is wide clinical variability; some patients have onset in infancy and show a rapidly progressive course with early death due to respiratory failure, whereas others have later onset of a slowly progressive myopathy.

Related Diseases for Mitochondrial Dna Depletion Syndrome 2

Symptoms & Phenotypes for Mitochondrial Dna Depletion Syndrome 2

Symptoms via clinical synopsis from OMIM:

57
Laboratory Abnormalities:
aminoaciduria
increased serum creatine kinase

Muscle Soft Tissue:
inability to walk
limb muscle weakness
gowers sign
loss of ability to walk in early childhood
hypotonia
more
Head And Neck Face:
facial diplegia

Respiratory:
respiratory insufficiency due to muscle weakness

Metabolic Features:
lactic acidosis


Clinical features from OMIM:

609560

Human phenotypes related to Mitochondrial Dna Depletion Syndrome 2:

32 (show all 22)
# Description HPO Frequency HPO Source Accession
1 seizures 32 HP:0001250
2 muscular hypotonia 32 HP:0001252
3 hearing impairment 32 HP:0000365
4 aminoaciduria 32 HP:0003355
5 respiratory insufficiency due to muscle weakness 32 HP:0002747
6 elevated serum creatine phosphokinase 32 HP:0003236
7 irritability 32 HP:0000737
8 lactic acidosis 32 HP:0003128
9 ragged-red muscle fibers 32 HP:0003200
10 intellectual disability, progressive 32 HP:0006887
11 facial diplegia 32 HP:0001349
12 generalized hypotonia 32 HP:0001290
13 limb muscle weakness 32 HP:0003690
14 gowers sign 32 HP:0003391
15 generalized amyotrophy 32 HP:0003700
16 delayed gross motor development 32 HP:0002194
17 cerebral atrophy 32 HP:0002059
18 abnormality of the basal ganglia 32 HP:0002134
19 decreased activity of mitochondrial respiratory chain 32 HP:0008972
20 loss of ability to walk in early childhood 32 HP:0008945
21 emg 32 HP:0003458
22 depletion of mitochondrial dna in muscle tissue 32 HP:0009141

Drugs & Therapeutics for Mitochondrial Dna Depletion Syndrome 2

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Treatment of TK2 Deficiency With Thymidine and Deoxycytidine Enrolling by invitation NCT03639701 Phase 1, Phase 2 Thymidine

Search NIH Clinical Center for Mitochondrial Dna Depletion Syndrome 2

Genetic Tests for Mitochondrial Dna Depletion Syndrome 2

Genetic tests related to Mitochondrial Dna Depletion Syndrome 2:

# Genetic test Affiliating Genes
1 Mitochondrial Dna Depletion Syndrome 2 29 TK2

Anatomical Context for Mitochondrial Dna Depletion Syndrome 2

MalaCards organs/tissues related to Mitochondrial Dna Depletion Syndrome 2:

41
Skeletal Muscle, Liver, Bone, Eye

Publications for Mitochondrial Dna Depletion Syndrome 2

Articles related to Mitochondrial Dna Depletion Syndrome 2:

# Title Authors Year
1
TK2-Related Mitochondrial DNA Depletion Syndrome, Myopathic Form ( 23230576 )
1993

Variations for Mitochondrial Dna Depletion Syndrome 2

UniProtKB/Swiss-Prot genetic disease variations for Mitochondrial Dna Depletion Syndrome 2:

75
# Symbol AA change Variation ID SNP ID
1 TK2 p.Ile53Met VAR_019419 rs137854432
2 TK2 p.Thr108Met VAR_019420 rs137854431
3 TK2 p.His121Asn VAR_019421 rs137854429
4 TK2 p.Ile212Asn VAR_019422 rs137854430
5 TK2 p.Thr64Met VAR_023790 rs281865487
6 TK2 p.Arg183Trp VAR_023791 rs137886900
7 TK2 p.Arg192Lys VAR_023792 rs281865496
8 TK2 p.Met117Val VAR_072789
9 TK2 p.Ala139Val VAR_072790 rs281865494

ClinVar genetic disease variations for Mitochondrial Dna Depletion Syndrome 2:

6 (show top 50) (show all 70)
# Gene Variation Type Significance SNP ID Assembly Location
1 TK2 NM_004614.4(TK2): c.361C> A (p.His121Asn) single nucleotide variant Pathogenic rs137854429 GRCh37 Chromosome 16, 66565297: 66565297
2 TK2 NM_004614.4(TK2): c.361C> A (p.His121Asn) single nucleotide variant Pathogenic rs137854429 GRCh38 Chromosome 16, 66531394: 66531394
3 TK2 NM_004614.4(TK2): c.635T> A (p.Ile212Asn) single nucleotide variant Pathogenic rs137854430 GRCh37 Chromosome 16, 66547698: 66547698
4 TK2 NM_004614.4(TK2): c.635T> A (p.Ile212Asn) single nucleotide variant Pathogenic rs137854430 GRCh38 Chromosome 16, 66513795: 66513795
5 TK2 NM_004614.4(TK2): c.323C> T (p.Thr108Met) single nucleotide variant Pathogenic rs137854431 GRCh37 Chromosome 16, 66565335: 66565335
6 TK2 NM_004614.4(TK2): c.323C> T (p.Thr108Met) single nucleotide variant Pathogenic rs137854431 GRCh38 Chromosome 16, 66531432: 66531432
7 TK2 NM_004614.4(TK2): c.159C> G (p.Ile53Met) single nucleotide variant Pathogenic rs137854432 GRCh37 Chromosome 16, 66575854: 66575854
8 TK2 NM_004614.4(TK2): c.159C> G (p.Ile53Met) single nucleotide variant Pathogenic rs137854432 GRCh38 Chromosome 16, 66541951: 66541951
9 TK2 NM_004614.4: c.-270+2561delins;7287-7335inv insertion Pathogenic
10 TK2 NM_001040138.2(CKLF): c.-7863_-2035delinsoAC010542.7: g.65062_65110 indel Pathogenic GRCh37 Chromosome 16, 66578756: 66584584
11 TK2 NM_001040138.2(CKLF): c.-7863_-2035delinsoAC010542.7: g.65062_65110 indel Pathogenic GRCh38 Chromosome 16, 66544853: 66550681
12 TK2 NM_004614.4(TK2): c.129_132delAGAA (p.Lys43Asnfs) deletion Pathogenic rs281865500 GRCh37 Chromosome 16, 66582905: 66582908
13 TK2 NM_004614.4(TK2): c.129_132delAGAA (p.Lys43Asnfs) deletion Pathogenic rs281865500 GRCh38 Chromosome 16, 66549002: 66549005
14 TK2 NM_004614.4(TK2): c.133C> T (p.Gln45Ter) single nucleotide variant Pathogenic rs281865486 GRCh37 Chromosome 16, 66582904: 66582904
15 TK2 NM_004614.4(TK2): c.133C> T (p.Gln45Ter) single nucleotide variant Pathogenic rs281865486 GRCh38 Chromosome 16, 66549001: 66549001
16 TK2 NM_004614.4(TK2): c.142dupG (p.Glu48Glyfs) duplication Pathogenic rs281865503 GRCh37 Chromosome 16, 66582895: 66582895
17 TK2 NM_004614.4(TK2): c.142dupG (p.Glu48Glyfs) duplication Pathogenic rs281865503 GRCh38 Chromosome 16, 66548992: 66548992
18 TK2 NM_004614.4(TK2): c.150dupA (p.Ser51Ilefs) duplication Pathogenic rs281865504 GRCh37 Chromosome 16, 66582887: 66582887
19 TK2 NM_004614.4(TK2): c.150dupA (p.Ser51Ilefs) duplication Pathogenic rs281865504 GRCh38 Chromosome 16, 66548984: 66548984
20 TK2 NM_004614.4(TK2): c.156+2T> C single nucleotide variant Pathogenic rs281865499 GRCh37 Chromosome 16, 66582879: 66582879
21 TK2 NM_004614.4(TK2): c.156+2T> C single nucleotide variant Pathogenic rs281865499 GRCh38 Chromosome 16, 66548976: 66548976
22 TK2 NM_004614.4(TK2): c.173A> G (p.Asn58Ser) single nucleotide variant Likely pathogenic rs138439950 GRCh37 Chromosome 16, 66575840: 66575840
23 TK2 NM_004614.4(TK2): c.173A> G (p.Asn58Ser) single nucleotide variant Likely pathogenic rs138439950 GRCh38 Chromosome 16, 66541937: 66541937
24 TK2 NM_004614.4(TK2): c.191C> T (p.Thr64Met) single nucleotide variant Pathogenic rs281865487 GRCh37 Chromosome 16, 66575822: 66575822
25 TK2 NM_004614.4(TK2): c.191C> T (p.Thr64Met) single nucleotide variant Pathogenic rs281865487 GRCh38 Chromosome 16, 66541919: 66541919
26 TK2 NM_004614.4(TK2): c.198C> G (p.Cys66Trp) single nucleotide variant Pathogenic rs281865488 GRCh37 Chromosome 16, 66575815: 66575815
27 TK2 NM_004614.4(TK2): c.198C> G (p.Cys66Trp) single nucleotide variant Pathogenic rs281865488 GRCh38 Chromosome 16, 66541912: 66541912
28 TK2 NM_004614.4(TK2): c.218_219dupCG (p.Thr74Argfs) duplication Pathogenic rs281865505 GRCh37 Chromosome 16, 66575794: 66575795
29 TK2 NM_004614.4(TK2): c.218_219dupCG (p.Thr74Argfs) duplication Pathogenic rs281865505 GRCh38 Chromosome 16, 66541891: 66541892
30 TK2 NM_004614.4(TK2): c.268C> T (p.Arg90Cys) single nucleotide variant Likely pathogenic rs281865489 GRCh37 Chromosome 16, 66570884: 66570884
31 TK2 NM_004614.4(TK2): c.268C> T (p.Arg90Cys) single nucleotide variant Likely pathogenic rs281865489 GRCh38 Chromosome 16, 66536981: 66536981
32 TK2 NM_004614.4(TK2): c.278A> G (p.Asn93Ser) single nucleotide variant Pathogenic rs142291440 GRCh37 Chromosome 16, 66570874: 66570874
33 TK2 NM_004614.4(TK2): c.278A> G (p.Asn93Ser) single nucleotide variant Pathogenic rs142291440 GRCh38 Chromosome 16, 66536971: 66536971
34 TK2 NM_004614.4(TK2): c.334T> A (p.Tyr112Asn) single nucleotide variant Pathogenic rs281865490 GRCh37 Chromosome 16, 66565324: 66565324
35 TK2 NM_004614.4(TK2): c.334T> A (p.Tyr112Asn) single nucleotide variant Pathogenic rs281865490 GRCh38 Chromosome 16, 66531421: 66531421
36 TK2 NM_004614.4(TK2): c.335_336dupAT (p.Val113Metfs) duplication Pathogenic rs281865506 GRCh37 Chromosome 16, 66565322: 66565323
37 TK2 NM_004614.4(TK2): c.335_336dupAT (p.Val113Metfs) duplication Pathogenic rs281865506 GRCh38 Chromosome 16, 66531419: 66531420
38 TK2 NM_004614.4(TK2): c.360_361delGCinsAA (p.His121Asn) indel Pathogenic rs281865507 GRCh37 Chromosome 16, 66565297: 66565298
39 TK2 NM_004614.4(TK2): c.360_361delGCinsAA (p.His121Asn) indel Pathogenic rs281865507 GRCh38 Chromosome 16, 66531394: 66531395
40 TK2 NM_004614.4(TK2): c.373C> T (p.Gln125Ter) single nucleotide variant Pathogenic rs281865491 GRCh37 Chromosome 16, 66565285: 66565285
41 TK2 NM_004614.4(TK2): c.373C> T (p.Gln125Ter) single nucleotide variant Pathogenic rs281865491 GRCh38 Chromosome 16, 66531382: 66531382
42 TK2 NM_004614.4(TK2): c.388C> T (p.Arg130Trp) single nucleotide variant Pathogenic rs281865493 GRCh37 Chromosome 16, 66562958: 66562958
43 TK2 NM_004614.4(TK2): c.388C> T (p.Arg130Trp) single nucleotide variant Pathogenic rs281865493 GRCh38 Chromosome 16, 66529055: 66529055
44 TK2 NM_004614.4(TK2): c.389G> A (p.Arg130Gln) single nucleotide variant Pathogenic rs281865492 GRCh37 Chromosome 16, 66562957: 66562957
45 TK2 NM_004614.4(TK2): c.389G> A (p.Arg130Gln) single nucleotide variant Pathogenic rs281865492 GRCh38 Chromosome 16, 66529054: 66529054
46 TK2 NM_004614.4(TK2): c.760C> T (p.Arg254Ter) single nucleotide variant Pathogenic rs281865498 GRCh38 Chromosome 16, 66512006: 66512006
47 TK2 NM_004614.4(TK2): c.416C> T (p.Ala139Val) single nucleotide variant Pathogenic/Likely pathogenic rs281865494 GRCh37 Chromosome 16, 66562930: 66562930
48 TK2 NM_004614.4(TK2): c.416C> T (p.Ala139Val) single nucleotide variant Pathogenic/Likely pathogenic rs281865494 GRCh38 Chromosome 16, 66529027: 66529027
49 TK2 NM_004614.4(TK2): c.547C> G (p.Arg183Gly) single nucleotide variant Pathogenic rs137886900 GRCh37 Chromosome 16, 66551110: 66551110
50 TK2 NM_004614.4(TK2): c.547C> G (p.Arg183Gly) single nucleotide variant Pathogenic rs137886900 GRCh38 Chromosome 16, 66517207: 66517207

Expression for Mitochondrial Dna Depletion Syndrome 2

Search GEO for disease gene expression data for Mitochondrial Dna Depletion Syndrome 2.

Pathways for Mitochondrial Dna Depletion Syndrome 2

GO Terms for Mitochondrial Dna Depletion Syndrome 2

Sources for Mitochondrial Dna Depletion Syndrome 2

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....